JP Morgan Reiterates Neutral and PT of $28 on HealthSouth

JP Morgan reiterated its Neutral rating on HealthSouth HLS. At the same time, the rating agency left its price target on the company's stock unchanged at $28. On Wednesday, HLS lost 6.22% of its value to end the day at $23.37. Its shares rebounded in today's pre-market trading, rising 2.7% to stand around $24.